IP Group is the UK’s most active early-stage investor in science-based companies, having developed and supported more than 600 businesses across HealthTech, DeepTech and CleanTech.
We pioneered systematic university spin out investment 25 years ago and are now the largest investor in UK university spin outs, alongside Parkwalk, our EIS fund management business. We have also replicated our model in Australia.
University partnerships
The Group benefits from deep partnerships with leading research institutions, including the University of Oxford, the University of Cambridge, and Imperial College London, providing access to a pipeline of pioneering scientific research and IP. We also work closely with other university specific or ‘regional cluster’ market participants such as Northern Gritstone, for whom we manage the Northern Universities Venture Fund.
In Australia, we partner with partner with the Group of Eight and the University of Auckland.
We have experience in every stage of the business-building process and have built a network of trusted advisors, investors and partners over our 25-year history.
Our investment teams are experts in their fields with a deep understanding of HealthTech, DeepTech and CleanTech. The team also has many years’ experience ‘business building’, and navigating the strategic and commercial challenges involved with setting up and nurturing companies.
Access to capital
We support our portfolio companies with capital from our own balance sheet leveraged with capital that we manage on behalf of others, as well as capital from our network of co-investors.
By addressing the funding needs of the most innovative opportunities with the most efficient form of capital at each funding stage, we create both a vibrant innovation ecosystem and generate attractive returns for our capital providers.
Entrepreneurial flair
When it comes to responding to business challenges and opportunities, we operate with a co-founder mindset and are entrepreneurial, creative and flexible in our approach.